Comment on 'Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures'

Drug Saf. 2020 May;43(5):503-505. doi: 10.1007/s40264-020-00929-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Hypersensitivity*
  • Infusions, Intravenous
  • Iron*

Substances

  • Iron